🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It's no longer binary: normal or abnormal. We've known that A.I. can predict future risk of breast cancer from a mammogram jamanetwork.com/journals/jaman… Today the FDA approved an A.I. to do this for 5-year risk assessment clairity.com

🔴An Observational Study of Cardiovascular Outcomes of Tirzepatide vs GLP-1 Receptor Agonists 🚨New Real-World Evidence: Tirzepatide vs GLP-1 RAs for CV Outcomes in T2D A large observational study compares CV risk in patients treated with tirzepatide vs GLP-1 receptor agonists.

Cysteine depletion triggers adipose tissue thermogenesis and weight loss go.nature.com/43uySjS

Mazdutide, via its dual GLP-1/GCGR activation effects, exerts multifactorial neuroprotective-related improvements in cognitive function in male db/db mice id.elsevier.com/as/authorizati…

¿Sabes qué recomienda la SEIOMM sobre la vitamina D? En este vídeo junto a Esteban Jódar Gimeno lo explicamos visualmente para que no se te olvide nada doryos.com/recomendacione…

Impact of Statin Nonacceptance on Cardiovascular Outcomes in Patients With Diabetes | Journal of the American Heart Association ahajournals.org/doi/10.1161/JA…

The shift in cardiovascular disease. From reduction of heart attacks, coronary artery disease, and strokes to more atrial fibrillation ("the most common cardiovascular problem") thelancet.com/journals/lance…

Will initial use of GLP-1 medicines serve as a portal for endoscopic and surgical approaches to maintain #weightloss nature.com/articles/d4158… Nature News & Views Elie Dolgin

This study found several non-LDL cholesterol markers as risk-enhancing markers of cardiovascular disease: endocrinepractice.org/article/S1530-… #endocrinology #diabetes Elsevier Endocrinology & Diabetes Vin Tangpricha, MD, PhD

Clinical Decisions: Setting for Initial Education about Type 1 Diabetes nej.md/43RL7G3 #MedEd

Augmenting enteral protein did not improve outcomes for critically ill patients compared with standard protein levels in the intensive care setting. #CCR25 ja.ma/4ktkqhU

The sodium-glucose transporter (SGLT2) drugs for diabetes have some senolytic properties (getting rid of senescent cells) and better than expected health outcomes. They are candidate drugs for extending healthspan (as also reviewed in SUPER AGERS) by Alex Janin

In the real world, the use of semaglutide (Wegovy) and tirzepatide (Zepbound) produce far less weight loss than in the randomized clinical trials, largely because people discontinue using them early or use lower maintenance doses

#Surgery for the treatment of arterial #hypertension in patients with unilateral #adrenal #incidentalomas and mild autonomous #cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial thelancet.com/journals/landi… #MACS #adrenalectomy

Accelerating gene editing towards the clinic for Cardiometabolic disorders Verve Therapeutics Eli Lilly and Company investor.lilly.com/news-releases/…

The salicylate derivative SANA represents a first-in-class activator of creatine-dependent energy expenditure and thermogenesis, highlighting its potential as a therapeutic candidate for ‘diabesity’ #weightloss nature.com/articles/s4225…

New Phase1B data for Dapiglutide the GLP-1R-GLP-2R co-agonist #ADA2025 #weightloss globenewswire.com/news-release/2…

More preclinical data extending the anti-aversive actions of GIP through studies of Tirzepatide science.org/doi/10.1126/sc… Science Advances

Oral semaglutide reduced major adverse cardiovascular event outcomes independently of concomitant SGLT2i treatment Prespecified analysis SOUL Trial pmc.ncbi.nlm.nih.gov/articles/PMC12…

Online—Prevalence of #clinical #obesity versus #BMI-defined obesity among US adults: a cohort study thelancet.com/journals/landi… #FREE to read